Pursuant to Regulation 30 and 47 of SEBI(LODR) Regulations,2015, we are forwarding herewith copies of Newspaper clippings regarding Unaudited Consolidated & Standalone Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TCM Limited (formerly Travancore Chemical & Mfg. Co. Ltd.), a Kerala-based company with factories at Mettur Dam, Tuticorin and Kalady, has submitted to BSE copies of newspaper clippings containing its unaudited consolidated and standalone financial results for the quarter and six months ended 30 September 2025. The results were published on 12 November 2025 in Financial Express (English) and Deepika (Malayalam vernacular). As per the extract, standalone revenue from operations for Q2 FY26 was around Rs. 662 lakhs while the company reported a net loss with basic EPS of about Rs. (0.42) per share for the quarter. Reserves stood at approximately Rs. 3,096 lakhs against equity share capital of Rs. 747.79 lakhs. This is a routine compliance filing under Regulations 30 and 47 of SEBI's LODR Rules, 2015.
This is a procedural compliance filing rather than new material news — the financial numbers were already disclosed earlier via the Regulation 33 results filing. The continued losses and declining revenue trajectory suggest the stock may remain under pressure, but no fresh trigger is introduced by this particular announcement.